BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15176497)

  • 1. Total and biologically active serum-soluble CD154 in patients with chronic idiopathic urticaria.
    Garmendia JV; Zabaleta M; Blanca I; Bianco NE; De Sanctis JB
    Allergy Asthma Proc; 2004; 25(2):121-5. PubMed ID: 15176497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotype characteristics of peripheral blood mononuclear leukocytes of chronic idiopathic urticaria patients.
    Garmendia JV; Zabaleta M; Aldrey O; Rivera H; De Sanctis JB; Bianco NE; Blanca I
    Invest Clin; 2006 Dec; 47(4):361-9. PubMed ID: 17176904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals.
    Guttman-Yassky E; Bergman R; Maor C; Mamorsky M; Pollack S; Shahar E
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):35-9. PubMed ID: 17207165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet membrane CD154 and sCD154 in progressive peripheral arterial disease: a pilot study.
    Young RS; Naseem KM; Pasupathy S; Ahilathirunayagam S; Chaparala RP; Homer-Vanniasinkam S
    Atherosclerosis; 2007 Feb; 190(2):452-8. PubMed ID: 16777115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic autoimmune urticaria: frequency and association with immunological markers.
    Abd El-Azim M; Abd El-Azim S
    J Investig Allergol Clin Immunol; 2011; 21(7):546-50. PubMed ID: 22312939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating stem cell factor in patients with chronic idiopathic urticaria.
    Asero R; Tedeschi A; Lorini M; Gerosa M; Meroni P; Riboldi P
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):79-81. PubMed ID: 12877454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria.
    Najib U; Bajwa ZH; Ostro MG; Sheikh J
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):496-501. PubMed ID: 20084843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
    Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
    Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased circulating FcepsilonRII-bearing B-lymphocytes and serum levels of IL-4 in non-autoreactive chronic idiopathic urticaria.
    Mohamed RW; Fathy A; el-Sayed AE
    Egypt J Immunol; 2003; 10(2):9-18. PubMed ID: 15719607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma-soluble CD40 concentration in patients with chronic urticaria with positive autologous serum skin test.
    Jasinska T; Kasperska-Zajac A
    Br J Dermatol; 2013 Jun; 168(6):1356-7. PubMed ID: 23517276
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
    Tamura N; Kobayashi S; Kato K; Bando H; Haruta K; Oyanagi M; Kuriyama M; Kipps TJ; Hashimoto H
    J Rheumatol; 2001 Dec; 28(12):2583-90. PubMed ID: 11764201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE FcɛR1β polymorphism and risk of developing chronic spontaneous urticaria: A study in an ethnic Kashmiri population.
    Rasool R; Shera IA; Nissar S; Yousuf Q; Shah ZA
    Allergol Immunopathol (Madr); 2015; 43(3):243-8. PubMed ID: 24953255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total and biologically active CD154 in patients with SLE.
    de Sanctis JB; Garmendia JV; Chaurio R; Zabaleta M; Rivas L
    Autoimmunity; 2009 May; 42(4):263-5. PubMed ID: 19811271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction.
    Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM
    Int J Mol Sci; 2015 May; 16(6):12147-58. PubMed ID: 26030673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
    Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
    Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.
    Hocher B; Liefeldt L; Quaschning T; Kalk P; Ziebig R; Godes M; Relle K; Asmus G; Stasch JP
    J Am Soc Nephrol; 2007 Apr; 18(4):1323-30. PubMed ID: 17314326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
    Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
    Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria.
    Szegedi A; Irinyi B; Gál M; Hunyadi J; Dankó K; Kiss E; Sipka S; Szegedi G; Gyimesi E
    Br J Dermatol; 2006 Jul; 155(1):67-75. PubMed ID: 16792754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63.
    De Swerdt A; Van Den Keybus C; Kasran A; Cadot P; Neyens K; Coorevits L; Kochuyt AM; Degreef H; Ceuppens JL
    J Allergy Clin Immunol; 2005 Sep; 116(3):662-7. PubMed ID: 16159640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria.
    Gyimesi E; Sipka S; Dankó K; Kiss E; Hídvégi B; Gál M; Hunyadi J; Irinyi B; Szegedi A
    Br J Dermatol; 2004 Aug; 151(2):388-96. PubMed ID: 15327546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.